LON:RUA

RUA Life Sciences (RUA) Share Forecast, Price & News

GBX 15.74

+0.24 (+1.55%)

(As of 03:48 PM ET)

Compare

Today's Range: 15.01
▼
15.74
50-Day Range: 15.10
▼
30.85
52-Week Range: 15.01
▼
67

Volume: 20,674 shs
Average Volume: 49,906 shs
Market Capitalization: £3.49 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Insider Trades

About RUA Life Sciences (LON:RUA) Stock

RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Ayrshire, the United Kingdom.

RUA Price History

30 days | 90 days | 365 days | Advanced Chart

RUA Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive RUA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RUA Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Medical Devices
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:RUA
CUSIP: N/A
CIK: N/A
Web: www.rualifesciences.com
Phone: 44 1294 317073
Fax: N/A
Employees: 38
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX (0.08)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-2,000,000.00
Net Margins: -91.92%
Pretax Margin: N/A
Return on Equity: -35.55%
Return on Assets: -21.69%

Debt

Debt-to-Equity Ratio: 10.14
Current Ratio: 5.20
Quick Ratio: 7.32

Sales & Book Value

Annual Sales: £2.18 million
Price / Sales: 1.53
Cash Flow: GBX 6.27 per share
Price / Cash Flow: 2.40
Book Value: GBX 21 per share
Price / Book: 0.71

Miscellaneous

Outstanding Shares: 22,180,000
Free Float: N/A
Market Cap: £3.33 million
Optionable: Not Optionable
Beta: 1.15

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Mr. William Donald Brown (Age 59)
Exec. Chairman
Comp: $266.98k

Mr. Lachlan Arthur Smith (Age 43)
CFO & Director
Comp: $139k

Mr. John McKenna (Age 70)
Director of Clinical Marketing & Exec. Director
Comp: $73.78k

Dr. Caroline Stretton (Age 52)
Group MD & Director
Comp: $173.99k

Mr. Iain Crawford Anthony (Age 47)
Director of Vascular R&D, Quality, Clinical & Regulatory Affairs and Director
Comp: $139.29k

Kathryn Mary Full FCCA
Company Sec.

Key Competitors

View All Competitors

Insiders

Lachlan Smith
Bought 19,341 shares on 12/14/2022
Total: £1.04 M ($54.00/share)

View All Insider Transactions

RUA Stock - Frequently Asked Questions

How have RUA shares performed in 2023?: RUA Life Sciences' stock was trading at GBX 48.50 on January 1st, 2023. Since then, RUA shares have decreased by 69.1% and is now trading at GBX 15.01.
View the best growth stocks for 2023 here.
What is RUA Life Sciences' stock symbol?: RUA Life Sciences trades on the London Stock Exchange (LON) under the ticker symbol "RUA."

How do I buy shares of RUA Life Sciences?: Shares of RUA stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is RUA Life Sciences' stock price today?: One share of RUA stock can currently be purchased for approximately GBX 15.01.
How much money does RUA Life Sciences make?: RUA Life Sciences (LON:RUA) has a market capitalization of £3.33 million and generates £2.18 million in revenue each year. The company earns £-2,000,000.00 in net income (profit) each year or GBX (0.08) on an earnings per share basis.
How can I contact RUA Life Sciences?: RUA Life Sciences' mailing address is 2 Drummond Crescent, Irvine, Ayrshire KA11 5AN, United Kingdom. The official website for the company is www.rualifesciences.com. The company can be reached via phone at 44 1294 317073.

This page (LON:RUA) was last updated on 9/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial